Several clinical trials demonstrating the efficacy of VEGF inhibition for other cancers have been reported (Hurwitz et al, 2004; Sandler et al, 2006), and VEGF upregulation in tumour cells is considered to be a mechanism of resistance to EGFR inhibitors (Viloria Petit et al, 2001). Here, EGFR is linked to cancer.